Subsequent Neoplasm Risk after Modern Mediastinal Radiotherapy for Pediatric Hodgkin Lymphoma: Insights from a Multi-Institutional Children’s Oncology Group Trial

Key Points

• Increased neoplasm risk follows mediastinal radiotherapy for pediatric Hodgkin lymphoma, underscoring long-term monitoring needs.
• The study reports a significant increase in neoplasms, with 20% of patients affected within 15 years post-treatment.
• Multi-institutional trial findings highlight the association between radiotherapy and subsequent neoplasms in survivors.
• This study emphasizes potential long-term health risks for pediatric patients, calling for ongoing surveillance post-treatment.